Relmada Therapeutics Inc (RLMD) Insider Trading

Total insider buys:
  • $1,439,435.83
Total insider sells:
  • $9,744,532.36
Most recent insider trade:
  • Sept. 11, 2024
Most active insider trader:
  • Sergio Traversa
Trader NameDateTitleAmountPriceTypeTotal Value
Sept. 11, 2024CEO51,407$2.99Buy$153,706.93
Sept. 11, 2024CFO24,120$2.95Buy$71,154.00
Sept. 9, 2024CEO55,579$2.71Buy$150,619.09
Sept. 9, 2024Director13,000$2.56Buy$33,280.00
Sept. 9, 2024CFO8,194$2.55Buy$20,894.70
Jan. 31, 2024CEO27,460$4.00Buy$109,840.00
Jan. 31, 2024CFO6,875$4.06Buy$27,912.50
Jan. 30, 2024Insider14,500$3.87Buy$56,115.00
Jan. 29, 2024CEO31,541$3.71Buy$117,017.11
Jan. 29, 2024CFO10,800$3.65Buy$39,420.00
May 23, 2023Insider10,000$3.18Buy$31,800.00
Dec. 8, 2022CEO55,250$2.10Buy$116,025.00
June 30, 2022CEO16,012$19.13Sell$306,309.56
April 4, 2022Director10,000$30.04Sell$300,400.00
Sept. 22, 2021Director6,600$29.00Sell$191,400.00
July 15, 2021Director3,300$31.54Sell$104,082.00
June 1, 2021Director3,000$33.34Sell$100,020.00
April 1, 2021Director3,000$35.43Sell$106,290.00
March 10, 2021CFO2,373$35.11Sell$83,316.03
March 9, 2021Director5,000$35.71Sell$178,550.00
March 9, 2021CEO7,017$35.65Sell$250,156.05
March 8, 2021CFO100$35.00Sell$3,500.00
Feb. 10, 2021CFO2,410$35.20Sell$84,832.00
Feb. 10, 2021CEO1,930$35.28Sell$68,090.40
Feb. 8, 2021CEO3,313$35.03Sell$116,054.39
Feb. 8, 2021CFO3,603$35.04Sell$126,249.12
Feb. 8, 2021Director1,500$35.04Sell$52,560.00
Feb. 3, 2021CEO3,278$35.07Sell$114,959.46
Feb. 3, 2021CFO3,200$35.04Sell$112,128.00
Feb. 1, 2021Director3,000$33.63Sell$100,890.00
Jan. 27, 2021Director5,000$32.46Sell$162,300.00
Jan. 27, 2021CFO3,000$31.93Sell$95,790.00
Jan. 26, 2021CEO600$35.15Sell$21,090.00
Jan. 25, 2021Director1,300$35.27Sell$45,851.00
Jan. 25, 2021CFO1,280$35.27Sell$45,145.60
Jan. 22, 2021Director2,100$3,042.03Sell$6,388,263.00
Jan. 22, 2021CFO2,113$35.55Sell$75,117.15
Jan. 22, 2021CEO2,170$35.58Sell$77,208.60
Nov. 2, 2020Director3,000$30.29Sell$90,870.00
Sept. 1, 2020Director3,000$34.74Sell$104,220.00
Aug. 3, 2020Director3,000$35.74Sell$107,220.00
July 1, 2020Director3,000$43.89Sell$131,670.00
Oct. 18, 2019Director5,000$30.00Buy$150,000.00
May 14, 2019Director100,000$1.50Buy$150,000.00
Dec. 11, 2018Director5,000$1.21Buy$6,050.00
Oct. 12, 2018Director150,000$0.90Buy$135,000.00
Dec. 16, 2015Director1,100$3.43Buy$3,773.00
Dec. 15, 2015Director3,000$2.99Buy$8,970.00
Dec. 15, 2015CEO18,970$3.05Buy$57,858.50
First«1 of 1»Last
  • Insiders are both buying and selling Relmada Therapeutics Inc stock.

  • The insider traders at Relmada Therapeutics Inc are: Maged Shenouda, Sergio Traversa, Paul Edward Kelly, Charles J Casamento, Shreeram Agharkar, Charles J. Casamento, Chuck Ence, and Cedric O'gorman

  • The most active insider trader at Relmada Therapeutics Inc is Maged Shenouda with 13 trades.

  • Paul Edward Kelly has sold the most Relmada Therapeutics Inc stock with a total value of $7,428,324.00.

  • Sergio Traversa has bought the most Relmada Therapeutics Inc stock with a total value of $858,773.56.

  • The most recent insider trade for Relmada Therapeutics Inc was on Sept. 11, 2024.

  • The single biggest insider buy for Relmada Therapeutics Inc was from Sergio Traversa with a total value of $153,706.93 on Sept. 11, 2024.

  • The single biggest insider sell for Relmada Therapeutics Inc was from Paul Edward Kelly with a total value of $6,388,263.00 on Jan. 22, 2021.